United States · 
Who invested in Brenig Therapeutics?
Brenig Therapeutics's investors include New Enterprise Associates and OrbiMed.
United States · Series A startup
Who invested in Brenig Therapeutics
Funding summaryUpdated 26 Oct 2026
$65Mraised across 1 round since 2024, from 1 source
- Latest round
- Series A, $65MJul 2024
- Investors
- 2
The rounds
- Jul 2024Series A$65M
Source recordedSEC filing: $30M sold, first sale Jul 2024
Founders and team
From Brenig Therapeutics's own website: 2 on the team.
- Ruben KarapetianHead of Discovery Biology
- Vasily KazeyHead of Pharmacology
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Brenig Therapeutics
How much has Brenig Therapeutics raised?
Brenig Therapeutics has raised $65M across 1 round since 2024.
When did Brenig Therapeutics last raise?
Brenig Therapeutics's most recent round was a Series A of $65M in Jul 2024.
What was Brenig Therapeutics's biggest round?
Its most recent round, $65M in Jul 2024, is also its largest on record.
Who backed Brenig Therapeutics first?
Brenig Therapeutics's first round on record, in Jul 2024, was backed by New Enterprise Associates and OrbiMed.
What stage is Brenig Therapeutics at?
Brenig Therapeutics's latest named round is a Series A, in Jul 2024.
Where is Brenig Therapeutics based?
Brenig Therapeutics is based in the United States.
Companies like Brenig Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.